Biotech · Private company · San Carlos, CA, US
Siolta Therapeutics, Inc.
Track this companyFree. Adds Siolta Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- STMC-103HPhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- STMC-103HPhase 1 · Atopic Immunoglobulin E-Mediated Allergic DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Allergic Disease Onset Prevention StudyPHASE1_PHASE2 · COMPLETED · started Sep 1, 2021ClinicalTrials.gov NCT05003804 · fetched Nov 12, 2026
- A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise HealthyPHASE1 · UNKNOWN · started Oct 10, 2018ClinicalTrials.gov NCT03819881 · fetched Nov 12, 2026
NIH awards3
- Development of a multispecies live biotherapeutic product for the prevention of recurrent bacterial vaginosisFiscal year 2026 · $935.4KNIH RePORTER 5R44AI195248-02 · fetched Nov 12, 2026
- Development of a multispecies live biotherapeutic product for the prevention of recurrent bacterial vaginosisFiscal year 2025 · $529.5KNIH RePORTER 1R44AI195248-01 · fetched Nov 12, 2026
- Anaerobic Manufacturing and Molecular Analytical Process Optimization to Support Clinical Development of Live Biotherapeutic ProductsFiscal year 2024 · $948.8KNIH RePORTER 5R44AI170366-03 · fetched Nov 12, 2026